Strides Arcolab has informed about Press Release dated May 21, 2015 titled ‘Strides inks agreements to acquire a generic pharmaceutical business in Australia and related assets from Aspen for approximately A$380 million; Acquisition to be EPS accretive immediately’
The above information is a part of company’s filings submitted to BSE.